US Stock MarketDetailed Quotes

SIOX Sio Gene Therapies

Watchlist
  • 0.478000
  • 0.0000000.00%
15min DelayClose Feb 7 16:00 ET
35.36MMarket Cap-1225P/E (TTM)

Sio Gene Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
(FY)Mar 31, 2022
(Q4)Mar 31, 2022
(Q3)Dec 31, 2021
(Q2)Sep 30, 2021
(Q1)Jun 30, 2021
(FY)Mar 31, 2021
(Q4)Mar 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-82.33%4.48M
-84.54%3.28M
-28.39%8.53M
69.59%71.56M
7.10%13.08M
139.26%25.37M
121.97%21.2M
21.18%11.92M
-39.00%42.2M
-23.95%12.21M
Selling and administrative expenses
-36.37%2.6M
-69.83%2.94M
-22.47%2.99M
5.02%18.16M
-88.15%470K
-2.67%4.09M
117.06%9.75M
-16.83%3.86M
-21.61%17.29M
-22.75%3.97M
-General and administrative expense
-36.37%2.6M
-69.83%2.94M
-22.47%2.99M
5.02%18.16M
-88.15%470K
-2.67%4.09M
117.06%9.75M
-16.83%3.86M
-21.61%17.29M
-22.75%3.97M
Research and development costs
-91.15%1.88M
-97.06%336K
-31.22%5.54M
114.43%53.4M
52.91%12.61M
232.25%21.29M
126.33%11.45M
55.14%8.06M
-47.14%24.9M
-24.51%8.24M
Operating profit
82.33%-4.48M
84.54%-3.28M
28.39%-8.53M
-69.59%-71.56M
-7.10%-13.08M
-139.26%-25.37M
-121.97%-21.2M
-21.18%-11.92M
39.00%-42.2M
23.95%-12.21M
Net non-operating interest income expense
96.62%-27K
81.75%-799K
99.77%-1K
Non-operating interest expense
----
----
----
-96.62%27K
----
----
----
----
-81.75%799K
-99.77%1K
Other net income (expense)
659.04%464K
580.49%197K
552.63%124K
-100.38%-39K
-99.26%66K
15.31%-83K
92.93%-41K
-99.08%19K
662.81%10.36M
6,963.78%8.97M
Other non- operating income (expenses)
659.04%464K
580.49%197K
552.63%124K
-100.38%-39K
-99.26%66K
15.31%-83K
92.93%-41K
-99.08%19K
662.81%10.36M
6,963.78%8.97M
Income before tax
84.21%-4.02M
85.50%-3.08M
29.32%-8.41M
-119.47%-71.63M
-302.50%-13.04M
-137.82%-25.46M
-109.64%-21.24M
-38.93%-11.9M
54.79%-32.64M
80.21%-3.24M
Income tax
0
0
85.71%-4K
222.17%259K
211.96%287K
0
0
-193.33%-28K
-148.40%-212K
-67.38%92K
Net income
84.21%-4.02M
85.50%-3.08M
29.18%-8.41M
-121.70%-71.89M
-300.00%-13.32M
-142.07%-25.46M
-112.71%-21.24M
-38.12%-11.87M
55.35%-32.43M
79.99%-3.33M
Net income continuous Operations
84.21%-4.02M
85.50%-3.08M
29.18%-8.41M
-121.70%-71.89M
-300.00%-13.32M
-142.07%-25.46M
-112.71%-21.24M
-38.12%-11.87M
55.35%-32.43M
79.99%-3.33M
Minority interest income
Net income attributable to the parent company
84.21%-4.02M
85.50%-3.08M
29.18%-8.41M
-121.70%-71.89M
-300.00%-13.32M
-142.07%-25.46M
-112.71%-21.24M
-38.12%-11.87M
55.35%-32.43M
79.99%-3.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
84.21%-4.02M
85.50%-3.08M
29.18%-8.41M
-121.70%-71.89M
-300.00%-13.32M
-142.07%-25.46M
-112.71%-21.24M
-38.12%-11.87M
55.35%-32.43M
79.99%-3.33M
Basic earnings per share
85.71%-0.05
86.21%-0.04
31.25%-0.11
-58.06%-0.98
-260.00%-0.18
-75.00%-0.35
-38.10%-0.29
20.00%-0.16
78.84%-0.62
89.36%-0.05
Diluted earnings per share
85.71%-0.05
86.21%-0.04
31.25%-0.11
-58.06%-0.98
-260.00%-0.18
-75.00%-0.35
-38.10%-0.29
20.00%-0.16
78.84%-0.62
89.36%-0.05
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022(FY)Mar 31, 2022(Q4)Mar 31, 2022(Q3)Dec 31, 2021(Q2)Sep 30, 2021(Q1)Jun 30, 2021(FY)Mar 31, 2021(Q4)Mar 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -82.33%4.48M-84.54%3.28M-28.39%8.53M69.59%71.56M7.10%13.08M139.26%25.37M121.97%21.2M21.18%11.92M-39.00%42.2M-23.95%12.21M
Selling and administrative expenses -36.37%2.6M-69.83%2.94M-22.47%2.99M5.02%18.16M-88.15%470K-2.67%4.09M117.06%9.75M-16.83%3.86M-21.61%17.29M-22.75%3.97M
-General and administrative expense -36.37%2.6M-69.83%2.94M-22.47%2.99M5.02%18.16M-88.15%470K-2.67%4.09M117.06%9.75M-16.83%3.86M-21.61%17.29M-22.75%3.97M
Research and development costs -91.15%1.88M-97.06%336K-31.22%5.54M114.43%53.4M52.91%12.61M232.25%21.29M126.33%11.45M55.14%8.06M-47.14%24.9M-24.51%8.24M
Operating profit 82.33%-4.48M84.54%-3.28M28.39%-8.53M-69.59%-71.56M-7.10%-13.08M-139.26%-25.37M-121.97%-21.2M-21.18%-11.92M39.00%-42.2M23.95%-12.21M
Net non-operating interest income expense 96.62%-27K81.75%-799K99.77%-1K
Non-operating interest expense -------------96.62%27K-----------------81.75%799K-99.77%1K
Other net income (expense) 659.04%464K580.49%197K552.63%124K-100.38%-39K-99.26%66K15.31%-83K92.93%-41K-99.08%19K662.81%10.36M6,963.78%8.97M
Other non- operating income (expenses) 659.04%464K580.49%197K552.63%124K-100.38%-39K-99.26%66K15.31%-83K92.93%-41K-99.08%19K662.81%10.36M6,963.78%8.97M
Income before tax 84.21%-4.02M85.50%-3.08M29.32%-8.41M-119.47%-71.63M-302.50%-13.04M-137.82%-25.46M-109.64%-21.24M-38.93%-11.9M54.79%-32.64M80.21%-3.24M
Income tax 0085.71%-4K222.17%259K211.96%287K00-193.33%-28K-148.40%-212K-67.38%92K
Net income 84.21%-4.02M85.50%-3.08M29.18%-8.41M-121.70%-71.89M-300.00%-13.32M-142.07%-25.46M-112.71%-21.24M-38.12%-11.87M55.35%-32.43M79.99%-3.33M
Net income continuous Operations 84.21%-4.02M85.50%-3.08M29.18%-8.41M-121.70%-71.89M-300.00%-13.32M-142.07%-25.46M-112.71%-21.24M-38.12%-11.87M55.35%-32.43M79.99%-3.33M
Minority interest income
Net income attributable to the parent company 84.21%-4.02M85.50%-3.08M29.18%-8.41M-121.70%-71.89M-300.00%-13.32M-142.07%-25.46M-112.71%-21.24M-38.12%-11.87M55.35%-32.43M79.99%-3.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 84.21%-4.02M85.50%-3.08M29.18%-8.41M-121.70%-71.89M-300.00%-13.32M-142.07%-25.46M-112.71%-21.24M-38.12%-11.87M55.35%-32.43M79.99%-3.33M
Basic earnings per share 85.71%-0.0586.21%-0.0431.25%-0.11-58.06%-0.98-260.00%-0.18-75.00%-0.35-38.10%-0.2920.00%-0.1678.84%-0.6289.36%-0.05
Diluted earnings per share 85.71%-0.0586.21%-0.0431.25%-0.11-58.06%-0.98-260.00%-0.18-75.00%-0.35-38.10%-0.2920.00%-0.1678.84%-0.6289.36%-0.05
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg